TY  - JOUR 
T1  - ERRATUM - Pre-treatment of the beta3-adrenergic receptor agonist BRL37344 reduces <i>in vivo</i> myocardial ischemia/reperfusion injury by improving AMPK and SIRT1 activity and by suppressing mTOR and p70S6K signaling pathways
JO  - Brazilian Journal of Pharmaceutical Sciences
SN  - 1984-8250
UL  - 10.1590/s2175-97902023e23002-E
VL  - 62 
Y1  - 2026
PB  - Brasil 
ER  -